Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| PETMED EXPRESS INCPETS · Entity 7326 | Director · CEO & President | January 27, 2021 | January 28, 2021 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
PETMED EXPRESS INC
Report date January 27, 2021 · Filed January 28, 2021
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| COMMON STOCKSEC Table I · non-derivative | Direct | 337,800 |
Reported balance
After 2021-01-27 transaction · row 1
1 source rowRow 1 · 2021-01-27 · Sale · Disposed 60,000 · Balance 337,800 F1: The reported transactions are pursuant to a pre-arranged structured sales plan that is in accordance with both the Securities and Exchange Commission's Rule 10b5-1 and the PetMed Express, Inc. insider trading policy. |
Filing footnotes · ownership attribution and instrument terms
F1: The reported transactions are pursuant to a pre-arranged structured sales plan that is in accordance with both the Securities and Exchange Commission's Rule 10b5-1 and the PetMed Express, Inc. insider trading policy.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| January 27, 2021 Filed Jan 28, 2021 21:38 UTC | PETMED EXPRESS INC PETS · Entity 7326 | SaleCOMMON STOCK | 60,000 | $45.50 | $2,730,000.00 |
DisclosureSEC source: 0001437749-21-001502 · rdgdoc.xml · nonDerivative · entry 1 AKDAG MENDERES · CIK 0001254383 · Director · CEO & President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 337,800 F1 · shares: The reported transactions are pursuant to a pre-arranged structured sales plan that is in accordance with both the Securities and Exchange Commission's Rule 10b5-1 and the PetMed Express, Inc. insider trading policy. Read SEC document |
| July 31, 2020 Filed Aug 4, 2020 14:49 UTC | PETMED EXPRESS INC PETS · Entity 7326 | GrantCommon Stock | 37,800 | $31.20 | $1,179,360.00 |
DisclosureSEC source: 0001437749-20-016422 · rdgdoc.xml · nonDerivative · entry 1 AKDAG MENDERES · CIK 0001254383 · Director · CEO & President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 397,800 F1 · shares: Issued pursuant to the terms and conditions of the PetMed Express, Inc. 2016 Employee Equity Compensation Restricted Stock Plan, and held in escrow to be released over a one year period condition upon continued employment. Mr. Akdag retains voting rights over all the shares while in escrow. Read SEC document |
| July 16, 2020 Filed Jul 20, 2020 15:56 UTC | PETMED EXPRESS INC PETS · Entity 7326 | SaleCommon Stock | 30,000 | $41.00 | $1,230,000.00 |
DisclosureSEC source: 0001437749-20-015389 · rdgdoc.xml · nonDerivative · entry 1 AKDAG MENDERES · CIK 0001254383 · Director · CEO & President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 360,000 F1 · shares: The reported transactions are pursuant to a pre-arranged structured sales plan that is in accordance with both the Securities and Exchange Commission's Rule 10b5-1 and the PetMed Express, Inc. insider trading policy. Read SEC document |
| April 07, 2020 Filed Apr 8, 2020 15:04 UTC | PETMED EXPRESS INC PETS · Entity 7326 | SaleCommon Stock | 20,000 | $31.25 | $625,000.00 |
DisclosureSEC source: 0001437749-20-007303 · rdgdoc.xml · nonDerivative · entry 1 AKDAG MENDERES · CIK 0001254383 · Director · CEO & President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 390,000 F1 · shares: The reported transactions are pursuant to a pre-arranged structured sales plan that is in accordance with both the Securities and Exchange Commission's Rule 10b5-1 and the PetMed Express, Inc. insider trading policy. Read SEC document |
| April 06, 2020 Filed Apr 7, 2020 16:41 UTC | PETMED EXPRESS INC PETS · Entity 7326 | SaleCommon Stock | 20,000 | $30.25 | $605,000.00 |
DisclosureSEC source: 0001437749-20-007252 · rdgdoc.xml · nonDerivative · entry 2 AKDAG MENDERES · CIK 0001254383 · Director · CEO & President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 410,000 F1 · shares: The reported transactions are pursuant to a pre-arranged structured sales plan that is in accordance with both the Securities and Exchange Commission's Rule 10b5-1 and the PetMed Express, Inc. insider trading policy. Read SEC document |
| April 03, 2020 Filed Apr 7, 2020 16:41 UTC | PETMED EXPRESS INC PETS · Entity 7326 | SaleCommon Stock | 10,000 | $29.50 | $295,000.00 |
DisclosureSEC source: 0001437749-20-007252 · rdgdoc.xml · nonDerivative · entry 1 AKDAG MENDERES · CIK 0001254383 · Director · CEO & President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 430,000 F1 · shares: The reported transactions are pursuant to a pre-arranged structured sales plan that is in accordance with both the Securities and Exchange Commission's Rule 10b5-1 and the PetMed Express, Inc. insider trading policy. Read SEC document |
| February 21, 2020 Filed Feb 24, 2020 20:42 UTC | PETMED EXPRESS INC PETS · Entity 7326 | SaleCommon Stock | 10,000 | $29.00 | $290,000.00 |
DisclosureSEC source: 0001437749-20-003355 · rdgdoc.xml · nonDerivative · entry 1 AKDAG MENDERES · CIK 0001254383 · Director · CEO & President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 440,000 F1 · shares: The reported transactions are pursuant to a pre-arranged structured sales plan that is in accordance with both the Securities and Exchange Commission's Rule 10b5-1 and the PetMed Express, Inc. insider trading policy. Read SEC document |
| February 18, 2020 Filed Feb 19, 2020 14:54 UTC | PETMED EXPRESS INC PETS · Entity 7326 | SaleCommon Stock | 2,381 | $28.00 | $66,668.00 |
DisclosureSEC source: 0001437749-20-002975 · rdgdoc.xml · nonDerivative · entry 2 AKDAG MENDERES · CIK 0001254383 · Director · CEO & President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 450,000 F1 · shares: The reported transactions are pursuant to a pre-arranged structured sales plan that is in accordance with both the Securities and Exchange Commission's Rule 10b5-1 and the PetMed Express, Inc. insider trading policy. Read SEC document |
| February 14, 2020 Filed Feb 19, 2020 14:54 UTC | PETMED EXPRESS INC PETS · Entity 7326 | SaleCommon Stock | 57,619 | $28.11 | $1,619,670.09 |
DisclosureSEC source: 0001437749-20-002975 · rdgdoc.xml · nonDerivative · entry 1 AKDAG MENDERES · CIK 0001254383 · Director · CEO & President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 452,381 F1 · shares: The reported transactions are pursuant to a pre-arranged structured sales plan that is in accordance with both the Securities and Exchange Commission's Rule 10b5-1 and the PetMed Express, Inc. insider trading policy. Read SEC document |
| July 26, 2019 Filed Jul 30, 2019 17:16 UTC | PETMED EXPRESS INC PETS · Entity 7326 | GrantCommon Stock | 40,000 | $15.98 | $639,200.00 |
DisclosureSEC source: 0001437749-19-014914 · rdgdoc.xml · nonDerivative · entry 1 AKDAG MENDERES · CIK 0001254383 · Director · CEO & President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 510,000 F1 · shares: Issued pursuant to the terms and conditions of the PetMed Express, Inc. 2016 Employee Equity Compensation Restricted Stock Plan, and held in escrow to be released over a one year period condition upon continued employment. Mr. Akdag retains voting rights over all the shares while in escrow. Read SEC document |
| January 22, 2018 Filed Jan 24, 2018 14:41 UTC | PETMED EXPRESS INC PETS · Entity 7326 | SaleCommon Stock | 10,000 | $57.00 | $570,000.00 |
DisclosureSEC source: 0001437749-18-001023 · rdgdoc.xml · nonDerivative · entry 1 AKDAG MENDERES · CIK 0001254383 · Director · CEO & President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 470,000 F1 · shares: The reported transactions are pursuant to a pre-arranged structured sales plan that is in accordance with both the Securities and Exchange Commission's Rule 10b5-1 and the PetMed Express, Inc. insider trading policy. Read SEC document |
| January 12, 2018 Filed Jan 16, 2018 11:01 UTC | PETMED EXPRESS INC PETS · Entity 7326 | SaleCommon Stock | 10,000 | $53.00 | $530,000.00 |
DisclosureSEC source: 0001437749-18-000597 · rdgdoc.xml · nonDerivative · entry 2 AKDAG MENDERES · CIK 0001254383 · Director · CEO & President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 480,000 F1 · shares: The reported transactions are pursuant to a pre-arranged structured sales plan that is in accordance with both the Securities and Exchange Commission's Rule 10b5-1 and the PetMed Express, Inc. insider trading policy. Read SEC document |
| January 11, 2018 Filed Jan 16, 2018 11:01 UTC | PETMED EXPRESS INC PETS · Entity 7326 | SaleCommon Stock | 30,000 | $51.00 | $1,530,000.00 |
DisclosureSEC source: 0001437749-18-000597 · rdgdoc.xml · nonDerivative · entry 1 AKDAG MENDERES · CIK 0001254383 · Director · CEO & President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 490,000 F1 · shares: The reported transactions are pursuant to a pre-arranged structured sales plan that is in accordance with both the Securities and Exchange Commission's Rule 10b5-1 and the PetMed Express, Inc. insider trading policy. Read SEC document |
| December 13, 2016 Filed Dec 14, 2016 20:54 UTC | PETMED EXPRESS INC PETS · Entity 7326 | SaleCommon Stock | 10,000 | $23.00 | $230,000.00 |
DisclosureSEC source: 0001553350-16-002804 · akdag4.xml · nonDerivative · entry 1 AKDAG MENDERES · CIK 0001254383 · Director · CEO & President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 520,000 F1 · shares: The reported transactions are pursuant to a pre-arranged structured sales plan that is in accordance with both the Securities and Exchange Commission's Rule 10b5-1 and the PetMed Express, Inc. insider trading policy. Read SEC document |
| December 07, 2016 Filed Dec 7, 2016 21:10 UTC | PETMED EXPRESS INC PETS · Entity 7326 | SaleCommon Stock | 2,674 | $22.75 | $60,833.50 |
DisclosureSEC source: 0001553350-16-002777 · akdag4.xml · nonDerivative · entry 2 AKDAG MENDERES · CIK 0001254383 · Director · CEO & President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 530,000 F1 · shares: The reported transactions are pursuant to a pre-arranged structured sales plan that is in accordance with both the Securities and Exchange Commission's Rule 10b5-1 and the PetMed Express, Inc. insider trading policy. Read SEC document |
| December 06, 2016 Filed Dec 7, 2016 21:10 UTC | PETMED EXPRESS INC PETS · Entity 7326 | SaleCommon Stock | 433 | $22.75 | $9,850.75 |
DisclosureSEC source: 0001553350-16-002777 · akdag4.xml · nonDerivative · entry 1 AKDAG MENDERES · CIK 0001254383 · Director · CEO & President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 532,674 F1 · shares: The reported transactions are pursuant to a pre-arranged structured sales plan that is in accordance with both the Securities and Exchange Commission's Rule 10b5-1 and the PetMed Express, Inc. insider trading policy. Read SEC document |
| December 01, 2016 Filed Dec 5, 2016 18:28 UTC | PETMED EXPRESS INC PETS · Entity 7326 | SaleCommon Stock | 16,893 | $22.60 | $381,781.80 |
DisclosureSEC source: 0001553350-16-002769 · akdag4.xml · nonDerivative · entry 1 AKDAG MENDERES · CIK 0001254383 · Director · CEO & President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 533,107 F1 · shares: The reported transactions are pursuant to a pre-arranged structured sales plan that is in accordance with both the Securities and Exchange Commission's Rule 10b5-1 and the PetMed Express, Inc. insider trading policy. Read SEC document |
| November 25, 2016 Filed Nov 29, 2016 19:05 UTC | PETMED EXPRESS INC PETS · Entity 7326 | SaleCommon Stock | 6,274 | $22.25 | $139,596.50 |
DisclosureSEC source: 0001553350-16-002744 · akdag4.xml · nonDerivative · entry 1 AKDAG MENDERES · CIK 0001254383 · Director · CEO & President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 550,000 F1 · shares: The reported transactions are pursuant to a pre-arranged structured sales plan that is in accordance with both the Securities and Exchange Commission's Rule 10b5-1 and the PetMed Express, Inc. insider trading policy. Read SEC document |
| November 21, 2016 Filed Nov 23, 2016 20:01 UTC | PETMED EXPRESS INC PETS · Entity 7326 | SaleCommon Stock | 3,726 | $22.25 | $82,903.50 |
DisclosureSEC source: 0001553350-16-002732 · akdag4.xml · nonDerivative · entry 1 AKDAG MENDERES · CIK 0001254383 · Director · CEO & President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 556,274 F1 · shares: The reported transactions are pursuant to a pre-arranged structured sales plan that is in accordance with both the Securities and Exchange Commission's Rule 10b5-1 and the PetMed Express, Inc. insider trading policy. Read SEC document |
| November 14, 2016 Filed Nov 15, 2016 19:24 UTC | PETMED EXPRESS INC PETS · Entity 7326 | SaleCommon Stock | 30,000 | $21.75 | $652,500.00 |
DisclosureSEC source: 0001553350-16-002682 · akdag4.xml · nonDerivative · entry 2 AKDAG MENDERES · CIK 0001254383 · Director · CEO & President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 560,000 F1 · shares: The reported transactions are pursuant to a pre-arranged structured sales plan that is in accordance with both the Securities and Exchange Commission's Rule 10b5-1 and the PetMed Express, Inc. insider trading policy. Read SEC document |
| November 11, 2016 Filed Nov 15, 2016 19:24 UTC | PETMED EXPRESS INC PETS · Entity 7326 | SaleCommon Stock | 10,000 | $21.25 | $212,500.00 |
DisclosureSEC source: 0001553350-16-002682 · akdag4.xml · nonDerivative · entry 1 AKDAG MENDERES · CIK 0001254383 · Director · CEO & President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 590,000 F1 · shares: The reported transactions are pursuant to a pre-arranged structured sales plan that is in accordance with both the Securities and Exchange Commission's Rule 10b5-1 and the PetMed Express, Inc. insider trading policy. Read SEC document |
| October 10, 2016 Filed Oct 11, 2016 16:39 UTC | PETMED EXPRESS INC PETS · Entity 7326 | SaleCommon Stock | 10,000 | $21.00 | $210,000.00 |
DisclosureSEC source: 0001553350-16-002520 · akdag4.xml · nonDerivative · entry 1 AKDAG MENDERES · CIK 0001254383 · Director · CEO & President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 600,000 F1 · shares: The reported transactions are pursuant to a pre-arranged structured sales plan that is in accordance with both the Securities and Exchange Commission's Rule 10b5-1 and the PetMed Express, Inc. insider trading policy. Read SEC document |
| September 22, 2016 Filed Sep 26, 2016 19:50 UTC | PETMED EXPRESS INC PETS · Entity 7326 | SaleCommon Stock | 10,000 | $20.75 | $207,500.00 |
DisclosureSEC source: 0001553350-16-002495 · akdag4.xml · nonDerivative · entry 1 AKDAG MENDERES · CIK 0001254383 · Director · CEO & President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 610,000 F1 · shares: The reported transactions are pursuant to a pre-arranged structured sales plan that is in accordance with both the Securities and Exchange Commission's Rule 10b5-1 and the PetMed Express, Inc. insider trading policy. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.